IP Library Granted Patent US 11,109,316
Granted Patent B2
US 11,109,316 · App. 16/911,631 · Granted Aug 31, 2021

Methods of wireless communication in an infusion pump system

Inventors: Geoffrey A. Kruse (San Diego, CA); Michael Michaud (San Diego, CA)
Assignee: Tandem Diabetes Care, Inc.
H04W52/0229A61M5/172A61M5/1723H04M1/72412A61M2205/3561A61M2205/3584A61M2205/50A61M2205/505A61M2205/702A61M2205/8212A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,109,316
App. No.
16/911,631
Granted
Aug 31, 2021
Kind
B2
Abstract

Disclosed herein are methods for establishing communication protocols between wireless devices in infusion pump systems. Infusion pump systems can include a number of components capable of wireless communication with one or more other components including an infusion pump, a continuous glucose monitoring (CGM) system, a smartphone or other multi-purpose consumer electronic device and/or a dedicated remote controller for the infusion pump. Communications among these devices can be coordinated to increase efficiency and conserve battery power.

Claims (29)

1. A method of reducing battery consumption of an infusion pump system in an infusion pump system including an infusion pump, a remote control device for remotely controlling the infusion pump, and a continuous glucose monitoring system, comprising:

collecting data with the continuous glucose monitoring system;

establishing wireless communication between the continuous glucose monitoring system and both the infusion pump and the remote control device;

separating the data collected with the continuous glucose monitoring system into pump data that will be utilized to determine therapy parameters for the infusion pump and non-pump data relating to the continuous glucose monitoring system that are not used to determine therapy parameters for the infusion pump;

transmitting the pump data to the infusion pump; and

transmitting the non-pump data to the remote control device.

2. The method of claim 1 , wherein transmitting the pump data to the infusion pump and transmitting the non-pump data to the remote control device can be done at different times.

3. The method of claim 2 , wherein transmitting the pump data to the infusion pump occurs more frequently than transmitting the non-pump data to the remote control device.

4. The method of claim 1 , wherein the continuous glucose monitoring system comprises a glucose sensor and a transmitter.

5. The method of claim 1 , wherein the pump data includes data relating to glucose levels of a user.

6. The method of claim 1 , wherein the non-pump data includes diagnostic and performance data of the continuous glucose monitoring system.

7. The method of claim 1 , wherein the remote control device is a dedicated remote controller designed for use with the infusion pump.

8. The method of claim 1 , wherein the remote control device is a multi-purpose consumer electronic device.

9. The method of claim 8 , wherein the multi-purpose consumer electronic device is a smartphone.

10. The method of claim 8 , wherein the multi-purpose consumer electronic device is an electronic watch.

11. A method of reducing battery consumption of an infusion pump in an infusion pump system including an infusion pump, a remote control device for remotely controlling the infusion pump, and a continuous glucose monitoring system, comprising:

collecting data with the continuous glucose monitoring system;

establishing wireless communication between the continuous glucose monitoring system and both the infusion pump and the remote control device;

limiting data transmitted to the infusion pump by the continuous glucose monitoring to data critical to pump functions to preserve a battery of the infusion pump; and

transmitting collected data that is not transmitted to the infusion pump to the remote control device.

12. The method of claim 11 , wherein the data critical to pump functions comprises data that will be utilized to determine therapy parameters for the infusion pump.

13. The method of claim 11 , wherein transmitting data to the infusion pump occurs more frequently than transmitting data to the remote control device.

14. The method of claim 11 , wherein the continuous glucose monitoring system comprises a glucose sensor and a transmitter.

15. The method of claim 11 , wherein the data transmitted to the infusion pump includes data relating to glucose levels of a user.

16. The method of claim 11 , wherein the data transmitted to the remote control device includes diagnostic and performance data of the continuous glucose monitoring system.

17. The method of claim 11 , wherein the remote control device is a dedicated remote controller designed for use with the infusion pump.

18. The method of claim 11 , wherein the remote control device is a multi-purpose consumer electronic device.

19. The method of claim 18 , wherein the multi-purpose consumer electronic device is a smartphone.

20. The method of claim 18 , wherein the multi-purpose consumer electronic device is an electronic watch.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2020
From: KRUSE, GEOFFREY A.; MICHAUD, MICHAEL
To: TANDEM DIABETES CARE, INC.
Reel/Frame 053037/0039 →
Continuity (3)
Continuation 16725278 · Dec 23, 2019
Provisional Application 62784949 · Dec 26, 2018
Related Publication 20200329433A1 · Oct 15, 2020